Published in J Parasitol on April 01, 1983
Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18
Role of land-surface changes in arctic summer warming. Science (2005) 5.54
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet (1987) 2.98
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science (1985) 2.44
Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg (1986) 2.09
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science (1988) 2.09
Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science (1988) 2.00
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med (1986) 1.89
Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci U S A (1978) 1.82
Plasmodium berghei: cloning of the circumsporozoite protein gene. Exp Parasitol (1987) 1.80
Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol Biochem Parasitol (1985) 1.70
Haemoflagellates: commercially available liquid media for rapid cultivation. Parasitology (1978) 1.61
Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet (1980) 1.57
Testing of drugs for antileishmanial activity in golden hamsters infected with Leishmania donovani. Int J Parasitol (1977) 1.56
Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skin. Arch Dermatol (1974) 1.53
Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. N Engl J Med (1986) 1.51
Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science (1988) 1.45
Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis. J Immunol Methods (1983) 1.44
American cutaneous leishmaniasis. Int J Dermatol (1982) 1.39
Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line. Infect Immun (1983) 1.35
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster. Exp Parasitol (1983) 1.34
Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya. Am J Trop Med Hyg (1987) 1.33
Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries. J Appl Physiol (1985) (1987) 1.33
The antileishmanial activity of lepidines. Am J Trop Med Hyg (1978) 1.30
Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. Exp Parasitol (1987) 1.29
Rapid serodiagnosis of leptospirosis using the IgM-specific Dot-ELISA: comparison with the microscopic agglutination test. Am J Trop Med Hyg (1985) 1.28
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. Am J Trop Med Hyg (1989) 1.27
Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc Soc Exp Biol Med (1987) 1.23
Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother (1986) 1.22
Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci (1978) 1.19
New tissue schizontocidal antimalarial drugs. Bull World Health Organ (1981) 1.13
Susceptibility of five strains of mice to Babesia microti of human origin. J Parasitol (1979) 1.12
Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am J Trop Med Hyg (1982) 1.09
Trypanosoma cruzi: effects of anti-thymocyte serum in mice and neonatal thymectomy in rats. Exp Parasitol (1973) 1.07
Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann Trop Med Parasitol (1984) 1.06
Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother (1990) 1.06
Comparison of Plasmodium falciparum infections in Panamanian and Colombian owl monkeys. Am J Trop Med Hyg (1985) 1.05
Standardization of the dot enzyme-linked immunosorbent assay (Dot-ELISA) for human visceral leishmaniasis. Am J Trop Med Hyg (1984) 1.04
Thymus dependence of resistance to infection with Babesia microti of human origin in mice. Am J Trop Med Hyg (1980) 1.03
Correspondence: Transfer of immunity to T. cruzi. Trans R Soc Trop Med Hyg (1974) 1.03
Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen. Infect Immun (1988) 1.03
Nutritional iron status and susceptibility to Proteus mirabilis pyelonephritis in the rat. Can J Microbiol (1982) 1.02
Evaluating new antimalarial drugs against trophozoite induced Plasmodium cynomolgi malaria in rhesus monkeys. Am J Trop Med Hyg (1976) 1.02
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob Agents Chemother (1992) 1.01
Restriction endonuclease analysis of Leishmania kinetoplast DNA characterizes parasites responsible for visceral and cutaneous disease. Am J Trop Med Hyg (1984) 1.00
Comparison of injectable haloperidol and chlorpromazine. Am J Psychiatry (1972) 0.99
Further characterization of Mycobacterium ulcerans toxin. Infect Immun (1978) 0.98
Influence of acetohydroxamic acid on experimental Corynebacterium renale pyelonephritis. Can J Microbiol (1977) 0.98
Killing of Leishmania tropica amastigotes by factors in normal human serum. J Immunol (1984) 0.97
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. Vaccine (1986) 0.97
Neutrophil kinetics in the pulmonary microcirculation during acute inflammation. Lab Invest (1991) 0.96
Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology. Vet Pathol (1984) 0.96
Visceral leishmaniasis in the German shepherd dog. II. Pathology. Vet Pathol (1984) 0.95
Cholelithiasis in dogs. J Am Vet Med Assoc (1973) 0.95
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus). Ann Trop Med Parasitol (1985) 0.95
Hematotropic parasites of translocated raccoons in the southeast. J Am Vet Med Assoc (1978) 0.95
The fine structure of the thymus of the fetal and neonatal monkey (Macaca mulatta). Z Zellforsch Mikrosk Anat (1971) 0.94
Identification of Leishmania spp. by multiple isozyme analysis. Am J Trop Med Hyg (1983) 0.93
In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1982) 0.93
Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci (1980) 0.92
Density of parasites in various organs and the relation to numbers of trypomastigotes in the blood during acute infections of Trypanosoma cruzi in mice. J Protozool (1974) 0.91
Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: antiprotozoal effects of some amidine types. Exp Parasitol (1981) 0.91
Plasmodium falciparum: sporozoite boosting of immunity due to a T-cell epitope on a sporozoite vaccine. Exp Parasitol (1987) 0.91
Prophylactic and therapeutic use of tetracycline during an epizootic of ehrlichiosis among military dogs. J Am Vet Med Assoc (1978) 0.91
Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg (1983) 0.91
Amyloidosis in rhesus monkeys with rheumatoid arthritis and enterocolitis. J Am Vet Med Assoc (1977) 0.90
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. Am J Vet Res (1984) 0.90
Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. Antimicrob Agents Chemother (1990) 0.90
The culture of Leishmania donovani in Schneider's insect medium: its value in the diagnosis and management of patients with visceral leishmaniasis. Trans R Soc Trop Med Hyg (1981) 0.89
Plasmodium gallinaceum: avian screen for drugs with radical curative properties. Exp Parasitol (1983) 0.89
Characterization of Kenyan Leishmania spp. and identification of Mastomys natalensis, Taterillus emini and Aethomys kaiseri as new hosts of Leishmania major. Ann Trop Med Parasitol (1986) 0.89
Comparison of the effects of neonatal thymectomy on plasmodium berghei, trypanosoma lewisi and trypanosoma cruzi infection in the albino rat. Z Parasitenkd (1974) 0.88
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway. Z Parasitenkd (1983) 0.88
Neutrophil kinetics in the pulmonary microcirculation. Effects of pressure and flow in the dependent lung. Am Rev Respir Dis (1990) 0.88
CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke (1997) 0.88
Influence of iron on Corynebacterium renale-induced pyelonephritis in a rat experimental model. Infect Immun (1978) 0.88
alpha-Difluoromethylornithine: a promising lead for preventive chemotherapy for coccidiosis. Am J Vet Res (1982) 0.88
Identification of pathogenic Leishmania promastigotes by DNA: DNA hybridization with kinetoplast DNA cloned into E. coli plasmids. Am J Trop Med Hyg (1985) 0.88